With 4 global laboratory locations, Q2 Solutions offers a range of next generation sequencing services to support drug discovery, precision medicine, and clinical development. We offer expertise in assay design, development, and validation, plus a translational genomics team comprised of both assay development and bioinformatic scientists, who lead the industry in high complexity testing and analysis. Q2 Solutions offers the following next generation sequencing services:
Service | Capability |
---|---|
Exome Sequencing |
|
RNA Sequencing | Capabilities include:
|
Whole Genome Sequencing | Optimized method for FFPE and intact material, using low input and minimal amplification |
DNA and RNA Isolations | DNA and RNA extraction capabilities from a large spectrum of original material, including FFPE, blood, tissue, and cells |
ThermoFisher in Ion Torrent AmpliSeq and Oncomine Panels |
|
NanoString nCounter Panels |
|
Bioinformatics |
|
As a leading laboratory services organization for trials across the globe, we integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize your...
Visium spatial profiling is a next-generation sequencing method that enables the analysis of cellular relationships by combining transcriptomics with histological techniques. It has advantages over...
This brochure highlights the specialty immunoassays performed by Rules-Based Medicine, a Q2 Solutions company. RBM provides an extensive menu of quantitative protein biomarkers, including multiplexed...